Yvonne Greenstreet
COO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Alnylam Pharmaceuticals, Inc. (ALNY) | Chief Executive Officer (principal executive officer) | $1,404,200 | $14,867,600 |
| 2024 | Alnylam Pharmaceuticals, Inc. (ALNY) | Chief Executive Officer (principal executive officer) | $1,253,400 | $11,492,970 |
| 2023 | Alnylam Pharmaceuticals, Inc. (ALNY) | Chief Executive Officer (principal executive officer) | $975,800 | $8,895,670 |
| 2022 | Alnylam Pharmaceuticals, Inc. (ALNY) | Chief Executive Officer (principal executive officer) | $850,000 | $4,588,810 |
| 2021 | Alnylam Pharmaceuticals, Inc. (ALNY) | MBChB, MBA Chief Executive Officer (principal executive officer) | $619,100 | $8,575,220 |
| 2020 | Alnylam Pharmaceuticals, Inc. (ALNY) | MBChB, MBA Chief Executive Officer (principal executive officer) | $621,500 | $3,034,001 |
| 2019 | Alnylam Pharmaceuticals, Inc. (ALNY) | MBChB, MBA President and Chief OperatingOfficer | $571,423 | $3,250,025 |
| 2018 | Alnylam Pharmaceuticals, Inc. (ALNY) | MBChB, MBA President and Chief OperatingOfficer | $540,000 | $2,682,755 |
| 2017 | Alnylam Pharmaceuticals, Inc. (ALNY) | MBChB, MBA ChiefOperating Officer | $504,200 | $984,674 |
Earnings-call appearances
-
Alnylam Pharmaceuticals Q2 2026 Earnings Conference Call2026-07-30
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q1 FY2026 Earnings Call2026-04-30
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q4 FY2025 Earnings Call2026-02-12
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q3 FY2025 Earnings Call2025-10-30
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q2 FY2025 Earnings Call2025-07-31
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q1 FY2025 Earnings Call2025-03-31
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q4 FY2024 Earnings Call2025-01-13
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-09-30
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q2 FY2024 Earnings Call2024-06-30
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-03-31
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q4 FY2023 Earnings Call2024-01-08
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q3 FY2023 Earnings Call2023-11-02
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q2 FY2023 Earnings Call2023-08-03
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q1 FY2023 Earnings Call2023-05-04
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q4 FY2022 Earnings Call2023-02-23
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q3 FY2022 Earnings Call2022-10-27
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q2 FY2022 Earnings Call2022-07-28
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q1 FY2022 Earnings Call2022-04-28
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q4 FY2021 Earnings Call2022-02-10
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q3 FY2021 Earnings Call2021-10-28
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q2 FY2021 Earnings Call2021-08-03
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q1 FY2021 Earnings Call2021-04-29
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q4 FY2020 Earnings Call2021-02-11
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q3 FY2020 Earnings Call2020-11-05
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q2 FY2020 Earnings Call2020-08-06
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q1 FY2020 Earnings Call2020-05-06
Alnylam Pharmaceuticals, Inc. (ALNY)